Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Priveterra Acquisition Corp. (Nasdaq: PMGM) (“Priveterra” and, after the consummation of its pending business combination (the “Business Combination”) and following its name change to AEON Biopharma, Inc., “New AEON”) today announced that, upon the Business Combination with AEON Biopharma, Inc, (“AEON”) following which AEON will be a wholly owned subsidiary of Priveterra … [Read more…]

AmeriHealth Caritas Announces That Paul Tufano Is Stepping Down as CEO

A national search for a permanent replacement is being initiated NEWTOWN SQUARE, Pa.–(BUSINESS WIRE)–#AmeriHealthCaritas—AmeriHealth Caritas, a national leader in Medicaid managed care and health care solutions for those most in need, announced today that Paul A. Tufano is stepping down as CEO of the company, effective September 1. A national search for the company’s new … [Read more…]

Krishna K. Maridi Joins Sonrava Health as Chief Financial Officer

DALLAS–(BUSINESS WIRE)–Krishna K. Maridi has joined Sonrava Health as Chief Financial Officer (CFO) effective July 10. Sonrava Health is a national family of health and wellness companies – including differentiated dental office brands, dental and vision benefit plans, provider networks, and consumer products and services – focused on quality, value and innovation. Mr. Maridi comes … [Read more…]

New Corporate Wellness Programs Unveiled to Enhance Employee Productivity and Improve Overall Well-being

AUSTIN, Texas–(BUSINESS WIRE)–Soul Pathology, a transformative force in wellness, resilience and personal growth serving employers, organizations and individuals, today announces its innovative wellness programs designed to empower employers and elevate employee well-being. The unveiling of these programs comes in direct response to recent studies demonstrating a direct link between employee productivity and well-being citing organizations … [Read more…]

CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring

AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that CareDx’s AlloSure® Lung donor-derived cell-free DNA (dd-cfDNA) molecular testing service has … [Read more…]

Hummingbird Diagnostics Announces Publication of miLung Small RNA-Based Blood Test for Early Detection of Lung Cancer in the Journal of Thoracic Oncology

Proprietary small RNA signature (miLung)-based blood test may support early lung cancer detection in primary care settings Results also presented in a poster at ASCO 2023 HEIDELBERG, Germany–(BUSINESS WIRE)–Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and characterization, today announced a publication in the Journal of Thoracic Oncology following … [Read more…]

First Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma

Partner Sanofi advances SAR’514 / IPH6401, a trifunctional anti-BCMA NKp46xCD16 NK cell engager from a joint research collaboration between Innate Pharma and Sanofi, to first-in-human clinical trial in relapsed/refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) Second molecule from Innate’s multi-specific NK cell engager platform ANKET® to progress to the clinic MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Innate … [Read more…]

KAID Health’s Natural Language Processing Solution Demonstrates Significant Promise in Tracking Persistent Postoperative Opioid Use

BOSTON–(BUSINESS WIRE)–KAID Health announced the publication of an important study, “Tracking Persistent Postoperative Opioid Use: A Proof-of-Concept Study Demonstrating a Use Case for Natural Language Processing,” in the journal Regional Anesthesia & Pain Medicine. The study showcases the effectiveness of KAID Health’s NLP solution in detecting prolonged postoperative opioid use, thus addressing a critical issue … [Read more…]

Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

– VRDN-001 data demonstrated clinically meaningful and rapid improvement in signs and symptoms of chronic TED at week 6 after receiving two infusions of VRDN-001 10 mg/kg or 3 mg/kg – – Ongoing THRIVE Phase 3 trial in patients with active TED amended to reflect Viridian’s confidence in 5-dose regimen and key stakeholder feedback on … [Read more…]

Hedonia’s Chief Scientific Officer, Professor Moshe Bar, explains: What is Facilitating Thought Progression (FTP)?

A therapeutic innovation that grew out of neuroscience puts the treatment of symptoms mood disorders in the palm of your hand TEL-AVIV, Israel–(BUSINESS WIRE)–Americans keep their smartphones close, as any mental health therapist knows from watching patients cradle their devices and check them furtively for messages. The Gallup Poll found that 91% of people between … [Read more…]